Abstract Body

Background: IFNα can inhibit acute HIV infection but is also associated with pathogenesis. The mechanism for this dual impact of IFNα remains unknown. There are 12 IFNα proteins but only one, IFNα2, has been used clinically. The IFNα subtypes are biologically distinct yet difficult to distinguish due to their high sequence similarity. Here we develop a method based on next-generation sequencing (NGS) to enumerate the relative abundance of different IFNα subtype transcripts. We then determined the relative potency of each IFNα subtype using the Lamina Propria Aggregate Culture model (LPAC), which recreates infection of the gut-associated lymphoid tissue (GALT), a major site of early HIV-1 replication.

Methods: Primer sets for quantitative PCR and Illumina NGS were designed in highly conserved regions that encompass polymorphic sites that can be used for IFNα subtype classification. Since plasmacytoid dendritic cells (pDCs) are the major producers of IFNα and likely migrate to the GALT during acute infection, total IFNα was quantified in RNA from pDCs that were negatively selected from PBMCs and exposed to cell-free R5-tropic HIV-1 (Ba-L) for 6 hours. Moreover, IFNα subtype distribution was determined in LPAC cells ± HIV-1. To determine the potencies of individual IFNα subtypes, each IFNα subtype was added to LPAC cells once at 400pg/mL immediately post-infection with HIV-Bal normalized to 10ng p24/mL. Productive infection was assessed using intracellular p24 flow cytometry and infectious virion release by TZM.bl assay at 4dpi.

Results: Negatively selected pDCs showed an average IFNα induction of >400-fold after 6hrs post HIV-1 exposure (n=5, p=0.0087). NGS analyses showed differential expression of IFNα subtypes in pDCs and LPAC cells co-incubated with HIV-1. In particular, IFNα5, IFNα8, and IFNα1/13 were overrepresented in multiple ex vivo conditions. In 2 donors tested so far, IFNα8 was the most potent in restricting productive HIV-1 infection and infectious virion release whereas IFNa16 was the least potent.

Conclusions: We developed a method for quantifying IFNα transcript production and the subtype distribution in primary cells. IFNα subtypes are not equally potent at inhibiting HIV-1. IFNα8 appears to be both highly expressed and the most potent at restricting HIV-1 in an ex vivo model of mucosal R5-tropic HIV-1 infection. The novel method presented here will be used to test if IFNα subtype expression profiles correlate with chronic immune activation in chronic HIV infection.